As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
パーパス・バリュー 企業情報 パイプライン 再生誘導医薬®について 株主・投資家のみなさまへ 株式情報 IRライブラリー IRニュース 当社のサステナビリティ 採用情報 EN お問い合わせ 再生誘導医薬®について PRODUCTS ホーム 再生誘導医薬®について 再生誘導医薬®は、生きた細胞を一切用いることなく、『化合物の投与により、組織・臓器の再生を誘導する』新しい作用メカニズムに基づく医薬品です。再生誘導医薬®の投与によって…
News
StemRIM Inc. Announces Patent Registration In South Korea For Use Of Redasemtide As Additional Therapeutic Indication Of Cartilage Disorders
Read more
Report
StemRIM Inc, 4599:TYO summary - FT.com
Latest StemRIM Inc (4599:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Read more
Report
StemRIM Wins Russian Patent to Expand Redasemtide Use in Fatty Liver and NASH
Tipranks Press Release.
Read more
Report
StemRIM (4599.T) Stock Price, News, Quote & History - Yahoo Finance
Find the latest StemRIM (4599.T) stock quote, history, news and other vital information to help you with your stock trading and investing.
Read more
Report
StemRIM (4599.T) Income Statement - Yahoo Finance
Get the detailed quarterly/annual income statement for StemRIM (4599.T). Find out the revenue, expenses and profit or loss over the last fiscal year.
Read more
Report
Show more news
